The vaccine we’re testing in Australi... - Lung Conditions C...

Lung Conditions Community Forum

56,005 members66,635 posts

The vaccine we’re testing in Australia is based on a flu shot. Here’s how it could work against coronavirus.

2greys profile image
4 Replies

A new trial has begun in Victoria this week to evaluate a potential vaccine against COVID-19.

The vaccine is called NVX-CoV2373 and is from a US biotech company, Novavax.

The trial will be carried out across Melbourne and Brisbane, and is the first human trial of a vaccine specifically for COVID-19 to take place in Australia.

This vaccine is actually based on a vaccine that was already in development for influenza. But how might it work against SARS-CoV-2, the coronavirus that causes COVID-19?

theconversation.com/the-vac...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Dilly2 profile image
Dilly2

Sounds exciting stuff slot going on at the moment just keep out fingers crossed

katieoxo60 profile image
katieoxo60

Thanks 2greys for sharing info , sounds promising for Australia and maybe the world in time to come , its for us to remain optimistic .

jhorsf profile image
jhorsf

In 2015 the company received an $89 million grant from the Bill & Melinda Gates Foundation another Bill Gates controlled company

mrawnsley profile image
mrawnsley

That's good to know. Finally had my flu jab from Medicare and got a leaflet to read - something you don't get at the doctor's. Reassuring to see that my tingles in my right hand - I'm left handed so asked to have it in my right arm - are all normal side effects. Much better service that GP surgery. I booked online after ringing so many chemists to find they were out of stock or only did injections Mon-Fri!

Not what you're looking for?

You may also like...

‘Universal Covid vaccine’ could be developed within a year, Second-generation jab may work against all variants of coronavirus.

Scancell Holdings plc, (AIM:SCLP), the developer of novel immunotherapies is pleased to announce...

How the coronavirus could be prevented from invading a host cell.

How might the novel coronavirus be prevented from entering a host cell in an effort to thwart...

How can we make sure people get the second COVID-19 vaccine dose?

The light at the end of the pandemic tunnel is getting brighter. This week, the first health care...

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) - Oxford /AstraZenaca has now been peer reviewed.

Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against...

Oxford/AstraZeneca vaccine is up to 90% effective in preventing coronavirus, tests show.

This is a very important development for all of the 3rd world countries, it can be transported and...